Tag
Balram Viswanathan
2 articles
Sandu Pharmaceuticals FY26 Net Profit Up 23.2% with Board Changes
Sandu Pharmaceuticals reported FY26 revenue of ₹69.93 crore and net profit growth of 23.2% with a recommended dividend of ₹1 per share.
The company announced board changes including Balram Viswanathan
Sandu Pharmaceuticals 41st AGM Notice 2026
Sandu Pharmaceuticals schedules its 41st AGM for September 11, 2026, to be held virtually via video conferencing.
Key agenda items include declaring a ₹1 per share dividend, reappointing directors, an